These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Specificity of cell mediated cytotoxicity. I. Cytotoxic reactions in H-2 system after allogeneic sensitization in vivo]. Schulze HA, Brock J, Siegl E. Allerg Immunol (Leipz); 1982; 28(2):109-17. PubMed ID: 6182781 [Abstract] [Full Text] [Related]
24. Cell-cell interaction in graft-rejection responses: breakdown of tolerance to allo-class I H-2 antigens by helper T cells against other histocompatibility antigens simultaneously expressed on a graft. Kitagawa S, Sato S, Hori S, Hamaoka T, Fujiwara H. Transplant Proc; 1991 Feb 10; 23(1 Pt 1):96-8. PubMed ID: 1825007 [No Abstract] [Full Text] [Related]
25. T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2I region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset. Smith DM, McKisic M, Stuart FP, Fitch FW. Transplant Proc; 1989 Feb 10; 21(1 Pt 1):162-4. PubMed ID: 2650100 [No Abstract] [Full Text] [Related]
26. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells. Levy RB, Shearer GM. J Immunol; 1983 Apr 10; 130(4):1506-11. PubMed ID: 6187809 [Abstract] [Full Text] [Related]
31. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions. Germain RN, Bhattacharya A, Dorf ME, Springer TA. J Immunol; 1982 Mar 10; 128(3):1409-13. PubMed ID: 6173436 [Abstract] [Full Text] [Related]
32. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. Drobyski WR, Majewski D, Ozker K, Hanson G. J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263 [Abstract] [Full Text] [Related]
34. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens. Halliday GM, Odling KA, Muller HK. Cell Immunol; 1993 Oct 15; 151(2):291-9. PubMed ID: 8402936 [Abstract] [Full Text] [Related]
35. Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumor. Rogers MJ, Law LW, Pierotti MA, Parmiani G. Int J Cancer; 1980 Jan 15; 25(1):105-9. PubMed ID: 7399738 [Abstract] [Full Text] [Related]
36. Inhibition of mast cell sensitization by alloantibodies. Vaz EM, Miguel NM. Braz J Med Biol Res; 1981 Dec 15; 14(6):389-93. PubMed ID: 6086111 [Abstract] [Full Text] [Related]